Prescriber's Corner
Dabrafenib: A New Therapy for Use in BRAF-Mutated Metastatic Melanoma
Suzanne McGettigan, MSN, CRNP, AOCN®
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania
Author's disclosures of potential conflicts of interest are found at the end of this article.
Suzanne McGettigan, MSN, CRNP, AOCN®, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, PCAM 4 West, Philadelphia, PA 19104. E-mail: Suzanne.McGettigan@uphs.upenn.edu
J Adv Pract Oncol 2014;5:211–215 |
DOI: 10.6004/jadpro.2014.5.3.6 |
© 2014 Harborside Press®
For access to the full length article, please
sign in.
